NLS Pharmaceutics Ltd.
News
NLS Pharmaceutics (NASDAQ:NLSP) Trading 4.3% Higher
Ticker Report NLS Pharmaceutics Ltd. (NASDAQ:NLSP - Get Free Report)'s stock price was up 4.3% on Friday . The company traded as high as $0.19 and last traded at $0.18. Approximately 406,885 shares traded hands...\n more…
Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump
Benzinga U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining around 0.4% on Monday. The Dow traded up 0.02% to 40,598.43 while the NASDAQ rose 0.40% to 17,427.58. The S&P 500 also rose, gaining, 0.28% to 5,474.27.\n more…
NLS Pharmaceutics and Kadimastem Announce Binding Term Sheet to Merge
Accesswire The proposed transaction will create a Nasdaq-traded, biotechnology company with product candidates in advanced stages of clinical development and focused on advancing Kadimastem's allogeneic cell...\n more…
Short Interest in NLS Pharmaceutics Ltd. (NASDAQ:NLSP) Rises By 2,335.2%
Ticker Report NLS Pharmaceutics Ltd. (NASDAQ:NLSP - Get Free Report) was the target of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 5,170,000 shares...\n more…